Literature DB >> 15979287

Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia.

C Ervin Davis1, Dilip V Jeste, Lisa T Eyler.   

Abstract

We systematically reviewed twenty-one functional neuroimaging studies that used longitudinal designs to investigate the effects of medication treatments on brain functioning among patients with schizophrenia. The studies reviewed were comprised of functional magnetic resonance imaging and positron emission tomography research using a baseline and at least one follow-up. The present review summarizes the different effects of medication and disease status on brain function, with attention to functional normalization, specific drug effects, and comparisons of typical versus atypical antipsychotics. Particular emphasis is given to methodological limitations in the existing literature, including lack of reliability data, clinical heterogeneity among studies, and inadequate study designs and statistics. Suggestions are made for improving future longitudinal neuroimaging studies of treatment effects in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979287     DOI: 10.1016/j.schres.2005.05.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  27 in total

1.  Picturing neuroscience research through a human rights lens: imaging first-episode schizophrenic treatment-naive individuals.

Authors:  Marleen Eijkholt; James A Anderson; Judy Illes
Journal:  Int J Law Psychiatry       Date:  2012-02-02

Review 2.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

3.  Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis.

Authors:  P Fusar-Poli; M R Broome; P Matthiasson; J B Woolley; A Mechelli; L C Johns; P Tabraham; E Bramon; L Valmaggia; S C Williams; P McGuire
Journal:  Schizophr Bull       Date:  2009-08-07       Impact factor: 9.306

Review 4.  Converging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies.

Authors:  Ayse Sakalli Kani; Ann K Shinn; Kathryn E Lewandowski; Dost Öngür
Journal:  J Psychiatr Res       Date:  2016-10-19       Impact factor: 4.791

5.  Impact of cognitive performance on the reproducibility of fMRI activation in schizophrenia.

Authors:  Olivier Maïza; Bernard Mazoyer; Pierre-Yves Hervé; Annick Razafimandimby; Sonia Dollfus; Nathalie Tzourio-Mazoyer; Ole A Andreassen
Journal:  J Psychiatry Neurosci       Date:  2010-11       Impact factor: 6.186

6.  fMRI study of language activation in schizophrenia, schizoaffective disorder and in individuals genetically at high risk.

Authors:  Xiaobo Li; Craig A Branch; Babak A Ardekani; Hilary Bertisch; Chindo Hicks; Lynn E DeLisi
Journal:  Schizophr Res       Date:  2007-08-24       Impact factor: 4.939

7.  Association of Age at Onset and Longitudinal Course of Prefrontal Function in Youth With Schizophrenia.

Authors:  Tara A Niendam; Kimberly L Ray; Ana-Maria Iosif; Tyler A Lesh; Stefania R Ashby; Pooja K Patel; Jason Smucny; Emilio Ferrer; Marjorie Solomon; J Daniel Ragland; Cameron S Carter
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

8.  Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia.

Authors:  Veena Kumari; Emmanuelle R Peters; Dominic Fannon; Elena Antonova; Preethi Premkumar; Anantha P Anilkumar; Steven C R Williams; Elizabeth Kuipers
Journal:  Biol Psychiatry       Date:  2009-06-27       Impact factor: 13.382

9.  Smoking status as a potential confound in the BOLD response of patients with schizophrenia.

Authors:  Leonard Leyba; Andrew R Mayer; Randy L Gollub; Nancy C Andreasen; Vincent P Clark
Journal:  Schizophr Res       Date:  2008-08-05       Impact factor: 4.939

10.  Functional MRI of verbal self-monitoring in schizophrenia: performance and illness-specific effects.

Authors:  Veena Kumari; Dominic Fannon; Dominic H Ffytche; Vinodkumar Raveendran; Elena Antonova; Preethi Premkumar; Michael A Cooke; Ananatha P P Anilkumar; Steven C R Williams; Christopher Andrew; Louise C Johns; Cynthia H Y Fu; Philip K McGuire; Elizabeth Kuipers
Journal:  Schizophr Bull       Date:  2008-11-07       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.